New therapeutic options for autism spectrum disorder: experimental evidences

Diagnostic and Statistical Manual of Mental Disorders

American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369 · see citing works

Diagnostic and Statistical Manual of Mental Disorders

Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,841 · see citing works

Diagnostic and Statistical Manual of Mental Disorders, 5th ed.

Carter, M. J. (2014) · Therapeutic Recreation Journal · Cited by 15,154 · see citing works

Epigenetic Regulations of GABAergic Neurotransmission: Relevance for Neurological Disorders and Epigenetic Therapy

Shrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,949 · see citing works

Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014

Baio, J., Wiggins, L., Christensen, D. L., Maenner, M. J., Daniels, J., Warren, Z., Kurzius-Spencer, M., Zahorodny, W., Robinson, C., Rosenberg, et al. (2018) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6706a1 · Cited by 6,078 · see citing works

Model of autism: increased ratio of excitation/inhibition in key neural systems

Rubenstein, J. L. R., & Merzenich, M. M. (2003) · Genes, Brain and Behavior · doi:10.1034/j.1601-183x.2003.00037.x · Cited by 2,768 · see citing works

Synaptic, transcriptional and chromatin genes disrupted in autism

Study, T. D., De Rubeis, S., Autism, H. M. C. F., UK10K Consortium, The Autism Sequencing Consortium, He, X., Goldberg, A. P., Poultney, C. S., Samocha, K., Ercument Cicek, A., et al. (2014) · Nature · doi:10.1038/nature13772 · Cited by 2,746 · see citing works

Neocortical excitation/inhibition balance in information processing and social dysfunction

Yizhar, O., Fenno, L. E., Prigge, M., Schneider, F., Davidson, T. J., O’Shea, D. J., Sohal, V. S., Goshen, I., Finkelstein, J., Paz, J. T., et al. (2011) · Nature · doi:10.1038/nature10360 · Cited by 2,454 · see citing works

Advances in autism genetics: on the threshold of a new neurobiology

Abrahams, B. S., & Geschwind, D. H. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2346 · Cited by 1,866 · see citing works

Dendritic spine pathology in neuropsychiatric disorders

Penzes, P., Cahill, M. E., Jones, K. A., VanLeeuwen, J.-E., & Woolfrey, K. M. (2011) · Nature Neuroscience · doi:10.1038/nn.2741 · Cited by 1,523 · see citing works

Prevalence of autism spectrum disorder among children aged 8 Years - Autism and developmental disabilities monitoring network, 11 Sites, United States, 2014

Naarden Braun, K. V., Lopez, M., White, T., et al. (2023) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/y3kk-5x30 · Cited by 1,381 · see citing works

Altered synaptic plasticity in a mouse model of fragile X mental retardation

Huber, K. M., Gallagher, S. M., Warren, S. T., & Bear, M. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122205699 · Cited by 1,349 · see citing works

Reversal of Neurological Defects in a Mouse Model of Rett Syndrome

Guy, J., Gan, J., Selfridge, J., Cobb, S., & Bird, A. (2007) · Science · doi:10.1126/science.1138389 · Cited by 1,230 · see citing works

Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin

Dölen, G., Darvishzadeh, A., Huang, K. W., & Malenka, R. C. (2013) · Nature · doi:10.1038/nature12518 · Cited by 1,161 · see citing works

Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits

Peñagarikano, O., Abrahams, B. S., Herman, E. I., Winden, K. D., Gdalyahu, A., Dong, H., Sonnenblick, L. I., Gruver, R., Almajano, J., Bragin, A., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.040 · Cited by 1,075 · see citing works

Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010.

(2014) · PubMed · Cited by 1,039 · see citing works

Correction of Fragile X Syndrome in Mice

Dölen, G., Osterweil, E., Rao, B. S. S., Smith, G. B., Auerbach, B. D., Chattarji, S., & Bear, M. F. (2007) · Neuron · doi:10.1016/j.neuron.2007.12.001 · Cited by 979 · see citing works

Promoting social behavior with oxytocin in high-functioning autism spectrum disorders.

Andari, E., Duhamel, J.-R., Zalla, T., Herbrecht, E., Leboyer, M., & Sirigu, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910249107 · Cited by 941 · see citing works

Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis

Ehninger, D., Han, S., Shilyansky, C., Zhou, Y., Li, W., Kwiatkowski, D. J., Ramesh, V., & Silva, A. J. (2008) · Nature Medicine · doi:10.1038/nm1788 · Cited by 879 · see citing works

Oxytocin and the Neural Mechanisms Regulating Social Cognition and Affiliative Behavior

Ross, H. E., & Young, L. J. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.05.004 · Cited by 856 · see citing works

Plasma oxytocin levels in autistic children

Modahl, C., Green, L. A., Fein, D., Morris, M., Waterhouse, L., Feinstein, C., & Levin, H. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00439-3 · Cited by 728 · see citing works

Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles

Nasrallah, H. A. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002066 · Cited by 716 · see citing works

Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function

Won, H., Lee, H.-R., Gee, H. Y., Mah, W., Kim, J.-I., Lee, J., Ha, S., Chung, C., Jung, E. S., Cho, Y. S., et al. (2012) · Nature · doi:10.1038/nature11208 · Cited by 695 · see citing works

Autistic-like behaviour in Scn1a+/− mice and rescue by enhanced GABA-mediated neurotransmission

Han, S., Tai, C., Westenbroek, R. E., Yu, F. H., Cheah, C. S., Potter, G. B., Rubenstein, J. L., Scheuer, T., de la Iglesia, H. O., & Catterall, W. A. (2012) · Nature · doi:10.1038/nature11356 · Cited by 643 · see citing works

Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2

Strauss, K. A., Puffenberger, E. G., Huentelman, M. J., Gottlieb, S., Dobrin, S. E., Parod, J. M., Stephan, D. A., & Morton, D. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052773 · Cited by 630 · see citing works

Dendritic Spine Structural Anomalies in Fragile-X Mental Retardation Syndrome

Irwin, S. A. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.10.1038 · Cited by 626 · see citing works

Oxytocin-Mediated GABA Inhibition During Delivery Attenuates Autism Pathogenesis in Rodent Offspring

Tyzio, R., Nardou, R., Ferrari, D. C., Tsintsadze, T., Shahrokhi, A., Eftekhari, S., Khalilov, I., Tsintsadze, V., Brouchoud, C., Chazal, G., et al. (2014) · Science · doi:10.1126/science.1247190 · Cited by 601 · see citing works

Mutations causing syndromic autism define an axis of synaptic pathophysiology

Auerbach, B. D., Osterweil, E. K., & Bear, M. F. (2011) · Nature · doi:10.1038/nature10658 · Cited by 592 · see citing works

Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1

Costa, R. M., Federov, N. B., Kogan, J. H., Murphy, G. G., Stern, J. N. H., Ohno, M., Kucherlapati, R., Jacks, T., & Silva, A. J. (2002) · Nature · doi:10.1038/nature711 · Cited by 586 · see citing works

The serotonin system in autism spectrum disorder: From biomarker to animal models

Muller, C. L., Anacker, A. M. J., & Veenstra-VanderWeele, J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.11.010 · Cited by 531 · see citing works

Advances in Autism

Geschwind, D. H. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.053107.121225 · Cited by 512 · see citing works

Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome

Fernandez, F., Morishita, W., Zuniga, E., Nguyen, J., Blank, M., Malenka, R. C., & Garner, C. C. (2007) · Nature Neuroscience · doi:10.1038/nn1860 · Cited by 509 · see citing works

Maternal Oxytocin Triggers a Transient Inhibitory Switch in GABA Signaling in the Fetal Brain During Delivery

Tyzio, R., Cossart, R., Khalilov, I., Minlebaev, M., Hübner, C. A., Represa, A., Ben-Ari, Y., & Khazipov, R. (2006) · Science · doi:10.1126/science.1133212 · Cited by 485 · see citing works

Lack of Efficacy of Citalopram in Children With Autism Spectrum Disorders and High Levels of Repetitive Behavior: Citalopram Ineffective in Children With Autism

King, B. H., Hollander, E., Sikich, L., McCracken, J. T., Scahill, L., Bregman, J. D., Donnelly, C. L., Anagnostou, E., Dukes, K., Sullivan, L., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.30 · Cited by 482 · see citing works

Risperidone for the Core Symptom Domains of Autism: Results From the Study by the Autism Network of the Research Units on Pediatric Psychopharmacology

McDougle, C. J., Scahill, L. D., Aman, M. G., McCracken, J. T., Tierney, E., Davies, M., Arnold, L. E., Posey, D. J., Martin, A., GHUMAN, J. K., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.6.1142 · Cited by 477 · see citing works

SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients

Shcheglovitov, A., Shcheglovitova, O., Yazawa, M., Portmann, T., Shu, R., Sebastiano, V., Krawisz, A., Froehlich, W., Bernstein, J. A., Hallmayer, J. F., et al. (2013) · Nature · doi:10.1038/nature12618 · Cited by 470 · see citing works

GABA system dysfunction in autism and related disorders: From synapse to symptoms

Coghlan, S., Horder, J., Inkster, B., Méndez, M. A., Murphy, D., & Nutt, D. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.07.005 · Cited by 437 · see citing works

The Pathophysiology of Fragile X Syndrome

Penagarikano, O., Mulle, J. G., & Warren, S. T. (2007) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.8.080706.092249 · Cited by 420 · see citing works

Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)

Williams, K., Brignell, A., Randall, M., Silove, N., & Hazell, P. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004677.pub3 · Cited by 415 · see citing works

Oxytocin and autistic disorder: alterations in peptide forms

Green, L., Fein, D., Modahl, C., Feinstein, C., Waterhouse, L., & Morris, M. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01139-8 · Cited by 404 · see citing works

The serotonin system in autism

Cook, E. H., & LEVENTHAL, B. L. (1996) · Current Opinion in Pediatrics · doi:10.1097/00008480-199608000-00008 · Cited by 394 · see citing works

Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice

Lira, A., Zhou, M., Castanon, N., Ansorge, M. S., Gordon, J. A., Francis, J. H., Bradley-Moore, M., Lira, J., Underwood, M. D., Arango, V., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00696-6 · Cited by 385 · see citing works

Exogenous and evoked oxytocin restores social behavior in the <i>Cntnap2</i> mouse model of autism

Peñagarikano, O., Lázaro, M. T., Lu, X.-H., Gordon, A., Dong, H., Lam, H. A., Peles, E., Maidment, N. T., Murphy, N. P., Yang, X. W., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.3010257 · Cited by 378 · see citing works

The oxytocin receptor gene (OXTR) is associated with autism spectrum disorder: a meta-analysis

LoParo, D., & Waldman, I. D. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.77 · Cited by 343 · see citing works

Oxytocin enhances hippocampal spike transmission by modulating fast-spiking interneurons

Owen, S. F., Tuncdemir, S. N., Bader, P. L., Tirko, N. N., Fishell, G., & Tsien, R. W. (2013) · Nature · doi:10.1038/nature12330 · Cited by 339 · see citing works

Effects of STX209 (Arbaclofen) on Neurobehavioral Function in Children and Adults with Fragile X Syndrome: A Randomized, Controlled, Phase 2 Trial

Berry-Kravis, E. M., Hessl, D., Rathmell, B., Zarevics, P., Cherubini, M., Walton-Bowen, K., Mu, Y., Nguyen, D. V., Gonzalez-Heydrich, J., Wang, P. P., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004214 · Cited by 328 · see citing works

Autism: Many Genes, Common Pathways?

Geschwind, D. H. (2008) · Cell · doi:10.1016/j.cell.2008.10.016 · Cited by 328 · see citing works

The GABAA Receptor as a Therapeutic Target for Neurodevelopmental Disorders

Braat, S., & Kooy, R. F. (2015) · Neuron · doi:10.1016/j.neuron.2015.03.042 · Cited by 294 · see citing works

Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial

ARNOLD, L. E., AMAN, M. G., COOK, A. M., WITWER, A. N., HALL, K. L., THOMPSON, S., & RAMADAN, Y. (2006) · Journal of the American Academy of Child &amp; Adolescent Psychiatry · doi:10.1097/01.chi.0000231976.28719.2a · Cited by 260 · see citing works

The Emerging Picture of Autism Spectrum Disorder: Genetics and Pathology

Chen, J. A., Peñagarikano, O., Belgard, T. G., Swarup, V., & Geschwind, D. H. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040405 · Cited by 254 · see citing works

Functional Interaction Between NMDA and mGlu5 Receptors: Effects on Working Memory, Instrumental Learning, Motor Behaviors, and Dopamine Release

Homayoun, H., Stefani, M. R., Adams, B. W., Tamagan, G. D., & Moghaddam, B. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300417 · Cited by 252 · see citing works

Reversal of Disease-Related Pathologies in the Fragile X Mouse Model by Selective Activation of GABA _B Receptors with Arbaclofen

Henderson, C., Wijetunge, L., Kinoshita, M. N., Shumway, M., Hammond, R. S., Postma, F. R., Brynczka, C., Rush, R., Thomas, A., Paylor, R., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004218 · Cited by 249 · see citing works

Major defects in neocortical GABAergic inhibitory circuits in mice lacking the fragile X mental retardation protein

Selby, L., Zhang, C., & Sun, Q.-Q. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2006.11.062 · Cited by 245 · see citing works

A Longitudinal Investigation of Psychotropic and Non-Psychotropic Medication Use Among Adolescents and Adults with Autism Spectrum Disorders

Esbensen, A. J., Greenberg, J. S., Seltzer, M. M., & Aman, M. G. (2009) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-009-0750-3 · Cited by 225 · see citing works

Clinical and neural effects of six-week administration of oxytocin on core symptoms of autism

Watanabe, T., Kuroda, M., Kuwabara, H., Aoki, Y., Iwashiro, N., Tatsunobu, N., Takao, H., Nippashi, Y., Kawakubo, Y., Kunimatsu, A., et al. (2015) · Brain · doi:10.1093/brain/awv249 · Cited by 222 · see citing works

Memantine as Adjunctive Therapy in Children Diagnosed With Autistic Spectrum Disorders: An Observation of Initial Clinical Response and Maintenance Tolerability

Chez, M. G., Burton, Q., Dowling, T., Chang, M., Khanna, P., & Kramer, C. (2007) · Journal of Child Neurology · doi:10.1177/0883073807302611 · Cited by 221 · see citing works

The oxytocin system in drug discovery for autism: Animal models and novel therapeutic strategies

Modi, M. E., & Young, L. J. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.12.010 · Cited by 218 · see citing works

Plasma oxytocin concentrations and <i>OXTR</i> polymorphisms predict social impairments in children with and without autism spectrum disorder

Parker, K. J., Garner, J. P., Libove, R. A., Hyde, S. A., Hornbeak, K. B., Carson, D. S., Liao, C.-P., Phillips, J. M., Hallmayer, J. F., & Hardan, A. Y. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402236111 · Cited by 215 · cited 1× · see citing works

Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders

Ehninger, D., & Silva, A. J. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.10.002 · Cited by 212 · see citing works

A Pilot Study of <scp>d</scp>-Cycloserine in Subjects With Autistic Disorder

Posey, D. J., Kem, D. L., Swiezy, N. B., Sweeten, T. L., Wiegand, R. E., & McDougle, C. J. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.2115 · Cited by 199 · see citing works

Autism genetics: searching for specificity and convergence

Berg, J. M., & Geschwind, D. H. (2012) · Genome Biology · doi:10.1186/gb-2012-13-7-247 · Cited by 192 · see citing works

Oxytocin improves behavioural and neural deficits in inferring others’ social emotions in autism

Aoki, Y., Yahata, N., Watanabe, T., Takano, Y., Kawakubo, Y., Kuwabara, H., Iwashiro, N., Natsubori, T., Inoue, H., Suga, M., et al. (2014) · Brain · doi:10.1093/brain/awu231 · Cited by 187 · see citing works

Mitigation of Sociocommunicational Deficits of Autism Through Oxytocin-Induced Recovery of Medial Prefrontal Activity: A Randomized Trial

Watanabe, T., Abe, O., Kuwabara, H., Yahata, N., Takano, Y., Iwashiro, N., Natsubori, T., Aoki, Y., Takao, H., Kawakubo, Y., et al. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.3181 · Cited by 183 · see citing works

Autonomic and Neuroendocrine Responses to a Psychosocial Stressor in Adults with Autistic Spectrum Disorder

Jansen, L. M. C., Gispen-de Wied, C. C., Wiegant, V. M., Westenberg, H. G. M., Lahuis, B. E., & van Engeland, H. (2006) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0124-z · Cited by 177 · see citing works

Insulin-like growth factor-1 rescues synaptic and motor deficits in a mouse model of autism and developmental delay

Bozdagi, O., Tavassoli, T., & Buxbaum, J. D. (2013) · Molecular Autism · doi:10.1186/2040-2392-4-9 · Cited by 176 · see citing works

Acute and Long-Term Safety and Tolerability of Risperidone in Children with Autism

Aman, M. G., Arnold, L. E., McDougle, C. J., Vitiello, B., Scahill, L. D., Davies, M., McCracken, J. T., Tierney, E., Nash, P. L., Posey, D. J., et al. (2005) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2005.15.869 · Cited by 170 · see citing works

Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder

Cook, E. H., Arora, R. C., Anderson, G. M., Berry‐Kravis, E., Yan, S., Yeoh, H. C., Sklena, P. J., Charak, D., & LEVENTHAL, B. L. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90685-v · Cited by 166 · see citing works

Social deficits in IRSp53 mutant mice improved by NMDAR and mGluR5 suppression

Chung, W., Choi, S. Y., Lee, E., Park, H., Kang, J., Park, H., Choi, Y., Lee, D., Park, S.-G., Kim, R., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.3927 · Cited by 163 · see citing works

A retrospective study of memantine in children and adolescents with pervasive developmental disorders

Erickson, C. A., Posey, D. J., Stigler, K. A., Mullett, J. E., Katschke, A. R., & McDougle, C. J. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0518-9 · Cited by 159 · see citing works

Association of autism severity with a monoamine oxidase A functional polymorphism

Cohen, I., Liu, X., Schutz, C. K., White, B., Jenkins, E., Brown, W., & Holden, J. (2003) · Clinical Genetics · doi:10.1034/j.1399-0004.2003.00115.x · Cited by 152 · see citing works

Effects of intranasal oxytocin on social anxiety in males with fragile X syndrome

Hall, S. S., Lightbody, A. A., McCarthy, B. E., Parker, K. J., & Reiss, A. L. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.07.020 · Cited by 143 · see citing works

A pilot controlled trial of insulin-like growth factor-1 in children with Phelan-McDermid syndrome

Kolevzon, A. L., Bush, L., Wang, A. A., Halpern, D. B., Frank, Y., Grodberg, D., Rapaport, R., Tavassoli, T., Chaplin, W. F., Soorya, L. V., et al. (2014) · Molecular Autism · doi:10.1186/2040-2392-5-54 · Cited by 141 · see citing works

Risperidone versus haloperidol in children and adolescents with AD

Miral, S., Gencer, Ö., İnal-Emiroglu, F. N., Baykara, B., Baykara, A., & Dırık, E. (2007) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-007-0620-5 · Cited by 140 · see citing works

Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial

Asadabadi, M., Mohammadi, M.-R., Ghanizadeh, A. J., Modabbernia, A., Ashrafi, M., Hassanzadeh, E., Forghani, S., & Akhondzadeh, S. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2796-8 · Cited by 139 · see citing works

Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial

Ghaleiha, A., Asadabadi, M., Mohammadi, M.-R., Shahei, M., Tabrizi, M. H., Hajiaghaee, R., Hassanzadeh, E., & Akhondzadeh, S. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000880 · Cited by 134 · see citing works

Guanfacine in children with autism and/or intellectual disabilities

Handen, B. L., Sahl, R., & Hardan, A. Y. (2008) · Journal of Developmental &amp; Behavioral Pediatrics · doi:10.1097/dbp.0b013e3181739b9d · Cited by 126 · see citing works

STX209 (Arbaclofen) for Autism Spectrum Disorders: An 8-Week Open-Label Study

Erickson, C. A., Veenstra-VanderWeele, J. M., Melmed, R. D., McCracken, J. T., Ginsberg, L. D., Sikich, L., Scahill, L. D., Cherubini, M., Zarevics, P., Walton-Bowen, K. L., et al. (2013) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-013-1963-z · Cited by 125 · see citing works

Monoamine oxidase A and A/B knockout mice display autistic-like features

Bortolato, M., Godar, S. C., Alzghoul, L., Zhang, J., Darling, R. D., Simpson, K. L., Bini, V., Chen, K., Wellman, C. L., Lin, R. C. S., et al. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000715 · Cited by 118 · see citing works

Oxytocin and Autism: A Systematic Review of Randomized Controlled Trials

Preti, A., Melis, M., Siddi, S., Vellante, M., Doneddu, G., & Fadda, R. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2013.0040 · Cited by 114 · see citing works

Serotonin transporter gene and autism: a haplotype analysis in an Irish autistic population

Conroy, J., Meally, E., Kearney, G., Fitzgerald, M., Gill, M., & Gallagher, L. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001459 · Cited by 104 · see citing works

Loss of GABAergic neurons in the hippocampus and cerebral cortex of Engrailed-2 null mutant mice: Implications for autism spectrum disorders

Sgadó, P., Genovesi, S., Kalinovsky, A., Zunino, G., Macchi, F., Allegra, M., Murenu, E., Provenzano, G., Tripathi, P. P., Casarosa, S., et al. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.01.021 · Cited by 104 · see citing works

Low CD38 expression in lymphoblastoid cells and haplotypes are both associated with autism in a family‐based study

Lerer, E., Levi, S., Israel, S., Yaari, M., Nemanov, L., Mankuta, D., Yirmiya, N., & Ebstein, R. P. (2010) · Autism Research · doi:10.1002/aur.156 · Cited by 104 · see citing works

Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders

Francis, S. M., Sagar, A., Levin-Decanini, T., Liu, W., Carter, C. S., & Jacob, S. (2014) · Brain Research · doi:10.1016/j.brainres.2014.01.021 · Cited by 101 · see citing works

Oxytocin’s neurochemical effects in the medial prefrontal cortex underlie recovery of task-specific brain activity in autism: a randomized controlled trial

Aoki, Y., Watanabe, T., Abe, O., Kuwabara, H., Yahata, N., Takano, Y., Iwashiro, N., Natsubori, T., Takao, H., Kawakubo, Y., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.74 · Cited by 95 · see citing works

Melatonin in Autism Spectrum Disorders

Rossignol, D. A., & Frye, R. E. (2014) · Current Clinical Pharmacology · doi:10.2174/15748847113086660072 · Cited by 90 · see citing works

Autism genetics: searching for specificity and convergence

Berg, J. M., & Geschwind, D. H. (2012) · Genome biology · doi:10.1186/gb4034 · Cited by 87 · see citing works

Aripiprazole in the Treatment of Irritability in Pediatric Patients (Aged 6–17 Years) with Autistic Disorder: Results from a 52-Week, Open-Label Study

Marcus, R. N., Owen, R., Manos, G., Mankoski, R., Kamen, L., McQuade, R. D., Carson, W. H., Corey-Lisle, P. K., & Aman, M. G. (2011) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2009.0121 · Cited by 82 · see citing works

A Trial of D-Cycloserine to Treat Stereotypies in Older Adolescents and Young Adults With Autism Spectrum Disorder

Urbano, M. R., Okwara, L., Manser, P., Hartmann, K., Herndon, A. L., & Deutsch, S. I. (2014) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000033 · Cited by 75 · see citing works

Drug therapy for attention-deficit/hyperactivity disorder-like symptoms in autistic disorder

Hazell, P. (2007) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.2007.00995.x · Cited by 69 · see citing works

Developmentally Regulated Ca2+-Dependent Activator Protein for Secretion 2 (CAPS2) is Involved in BDNF Secretion and is Associated with Autism Susceptibility

Sadakata, T., & Furuichi, T. (2009) · The Cerebellum · doi:10.1007/s12311-009-0097-5 · Cited by 63 · see citing works

Genetic variation in CD38 and breastfeeding experience interact to impact infants’ attention to social eye cues

Krol, K. M., Monakhov, M. V., Lai, P. S., Ebstein, R. P., & Großmann, T. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1506352112 · Cited by 62 · see citing works

Oxytocin enhances orienting to social information in a selective group of high-functioning male adults with autism spectrum disorder

Althaus, M., Groen, Y., Wijers, A. A., Noltes, H., Tucha, O., & Hoekstra, P. J. (2015) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2015.10.025 · Cited by 57 · see citing works

The Therapeutic effect of Memantine through the Stimulation of Synapse Formation and Dendritic Spine Maturation in Autism and Fragile X Syndrome

Wei, H., Dobkin, C., Sheikh, A. M., Malik, M. N., Brown, W. T., & Li, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036981 · Cited by 55 · see citing works

Evidence for alterations in stimulatory G proteins and oxytocin levels in children with autism

Jacobson, J. D., Ellerbeck, K. A., Kelly, K., Fleming, K., Jamison, T. R., Coffey, C. W., Smith, C. M., Reese, R. M., & Sands, S. A. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.11.014 · Cited by 41 · see citing works

A Trial of D-Cycloserine to Treat the Social Deficit in Older Adolescents and Young Adults With Autism Spectrum Disorders

Urbano, M. R., Okwara, L., Manser, P., Hartmann, K., & Deutsch, S. I. (2015) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.13070155 · Cited by 40 · see citing works

Potential for treatment of severe autism in tuberous sclerosis complex

Gipson, T. (2013) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v2.i3.16 · Cited by 21 · see citing works

Can Bayesian Theories of Autism Spectrum Disorder Help Improve Clinical Practice?

Haker, H., Schneebeli, M., & Stephan, K. E. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00107 · Cited by 130 · see citing works

<scp>O</scp>xytocin modulation of neural circuits for social behavior

Marlin, B. J., & Froemke, R. C. (2017) · Developmental Neurobiology · doi:10.1002/dneu.22452 · Cited by 130 · see citing works

A Subset of Autism-Associated Genes Regulate the Structural Stability of Neurons

Lin, Y., Frei, J. A., Kilander, M. B. C., Shen, W., & Blatt, G. J. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00263 · Cited by 91 · see citing works

Involvement of Oxytocin Receptor/Erk/MAPK Signaling in the mPFC in Early Life Stress-Induced Autistic-Like Behaviors

Wei, J., Ma, L., Ju, P., Yang, B., Wang, Y., & Chen, J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.564485 · Cited by 37 · see citing works

Recapitulation of Neuropsychiatric Behavioral Features in Mice Using Acute Low-dose MK-801 Administration

Mabunga, D. F. N., Park, D., Ryu, O., Valencia, S. T., Adil, K. J., Kim, S., Kwon, K. J., Shin, C. Y., & Jeon, S. J. (2019) · Experimental Neurobiology · doi:10.5607/en.2019.28.6.697 · Cited by 27 · see citing works

Development of a Highly Potent Analogue and a Long-Acting Analogue of Oxytocin for the Treatment of Social Impairment-Like Behaviors

Ichinose, W., Михайлович, Ч. С., Shabalova, A. A., Yokoyama, S., Yuhi, T., Yamaguchi, H., Watanabe, A., Yamamoto, Y., Okamoto, H., Horike, S., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01691 · Cited by 30 · see citing works

Practitioner’s review: medication for children and adolescents with autism spectrum disorder (ASD) and comorbid conditions

Popow, C., Ohmann, S., & Plener, P. L. (2021) · Neuropsychiatrie · doi:10.1007/s40211-021-00395-9 · Cited by 36 · see citing works

Effects of Three Lipidated Oxytocin Analogs on Behavioral Deficits in CD38 Knockout Mice

Михайлович, Ч. С., Akther, S., Nishimura, T., Shabalova, A. A., Mizuno, A., Ichinose, W., Shuto, S., Yamamoto, Y., Yokoyama, S., & Higashida, H. (2017) · Brain Sciences · doi:10.3390/brainsci7100132 · Cited by 23 · see citing works

Aripiprazole for the treatment of irritability and aggression in children and adolescents affected by autism spectrum disorders

Rizzo, R., & Pavone, P. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1211007 · Cited by 19 · see citing works

New Assessments and Treatments in ASD

Choueiri, R., & Zimmerman, A. W. (2017) · Current Treatment Options in Neurology · doi:10.1007/s11940-017-0443-8 · Cited by 17 · see citing works

Role of FMRP in AKT/mTOR pathway-mediated hippocampal autophagy in fragile X syndrome

Zhang, B., Zhang, J., Chen, H., Qiao, D., Guo, F., Hu, X., Qin, C., Jin, X., Zhang, K., Wang, C., et al. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111036 · Cited by 14 · see citing works

Involvement of oxytocin receptor deficiency in psychiatric disorders and behavioral abnormalities

Wei, J., Zheng, H., Li, G., Chen, Z., Fang, G., & Yan, J. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1164796 · Cited by 13 · see citing works

Effects of Medical Cannabis Treatment for Autistic Children on Anxiety and Restricted and Repetitive Behaviors and Interests: An Open-Label Study

David, A., Stolar, O. E., Berkovitch, M., Kohn, E., Hazan, A., Waissengreen, D., & Gal, E. (2024) · Cannabis and Cannabinoid Research · doi:10.1089/can.2024.0001 · Cited by 5 · see citing works

Characteristics for Medical Cannabis Treatment Adherence among Autistic Children and Their Families: A Mixed-Methods Analysis

David, A., Stolar, O. E., Berkovitch, M., Kohn, E., Waisman-Nitzan, M., Hartmann, I., & Gal, E. (2024) · Medical Cannabis and Cannabinoids · doi:10.1159/000538901 · Cited by 4 · see citing works

Calcium Signaling and Molecular Adhesion Processes May Hold the Key to Genetic Risk for Autism: A Molecular Pathway Analysis on Two Independent Samples

Drago, A., Calabrò, M., & Crisafulli, C. (2024) · Genes · doi:10.3390/genes15121609 · Cited by 2 · see citing works

Enduring Autism-like Phenotypes and Deregulated Hypothalamic Prosocial Peptides After Early-Life Exposure to Indoor Flame Retardants in Male C57BL/6 MicePreprint

Kozlova, E. V., Gonzalez, G. M., Denys, M. E., Bishay, A. E., Gutierrez, R., Reid, J., Krum, J. M., Lampel, G., Luvsanravdan, N., Rabbani, K. M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.02.673882 · Cited by 1 · see citing works

Behavioral and Neuroanatomical Assessment of Transgenic Mouse Models of Language-related Developmental Disorders

Rendall, A. R. (2017) · OpenCommons - UConn (University of Connecticut)

New substitutions of mitochondrial DNA in Iranian autistic children

Akouchekian, M., Shooshtari, M. H., Heidary, H., & Moeinian, P. (2018) · Archives of Medical Science - Civilization Diseases · doi:10.5114/amscd.2018.78769

Oxitozina erabilgarria izan al daiteke autismoan gertatzen den urritasun sozialerako?

de Arechavaleta, C. R. D. M. R., Peñagarikano, O., & Erdozain, A. M. (2019) · EKAIA Euskal Herriko Unibertsitateko Zientzi eta Teknologi Aldizkaria · doi:10.1387/ekaia.20886

Practical Issues With Clonazepam Use

Kang, U. G., Kim, S. H., Choi, Y. S., Lee, K. Y., Kim, Y. S., & Chung, I. W. (2023) · 신경정신의학 · doi:10.4306/jknpa.2023.62.1.21

Efeitos da suplementação com probióticos no Transtorno do Espectro Autista: uma revisão sistemática

Barbosa, R. P. D. C., Barbosa, R. P. D. C., & Pureza, I. R. D. O. M. (2024) · Brazilian Journal of Health Review · doi:10.34119/bjhrv7n4-001

The Effect of Intranasal Oxytocin on Social Interaction in Adults and Children With Autism Spectrum Disorders: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Fang, G., Pan, W., Li, G., Ma, L., & Wei, J. (2026) · ALPHA PSYCHIATRY · doi:10.31083/ap45322

The impact of probiotic treatment on sex-specific behavioral differences in valproic acid-induced autism animal model

Mintál, K., Hormay, E., László, K., Kocsis, B., Kulcsár, G., Vörös, D., Vizvári, Z., Czifra, L., Petykó, Z., Cserjési, R., et al. (2026) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2026.101378

BindingDB Entry 50008916: Development of a Highly Potent Analogue and a Long-Acting Analogue of Oxytocin for the Treatment of Social Impairment-Like Behaviors.

BindingDB (2021) · UC San Diego · doi:10.7270/q2gf0xxq

Targets for Drug Therapy for Autism Spectrum Disorder: Challenges and Future Directions

Lacivita, E., Perrone, R., Margari, L., & Leopoldo, M. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00965 · Cited by 66 · see citing works

The promising trajectory of autism therapeutics discovery

Silverman, J. L., & Crawley, J. N. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.12.007 · Cited by 34 · see citing works

Pharmacotherapy in autism spectrum disorder

Smile, S., & Anagnostou, E. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-03056-2_5 · Cited by 1 · see citing works

New Models for Considering the Role of Medication in the Treatment and Elucidation of the Etiology of Autism

Smile, S., & Anagnostou, E. A. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0326-3 · Cited by 5 · see citing works

Autism Spectrum Disorder: The Different Forms of Pharmacological Treatment

Aragão, G. F. (2017) · Global Journal of Pharmacy & Pharmaceutical Sciences · doi:10.19080/gjpps.2017.04.555627 · Cited by 1 · see citing works